1 Introduction Over the past few months,there has been significant progress in the cancer research field.This article intends to present a brief review of representative breakthroughs.1.1 Cancer hallmarks and statistics In the 2022 January Issue of Cancer Discovery,Douglas Hanahan published the third ...
The 13 ENBDC committee members quickly reached a consensus on the greatest breakthroughs of the last decade. While some implicit bias cannot be excluded, there was unanimous agreement that the development and application of new technologies, in combination with key biological and clinical research ques...
Lung cancer, a multifaceted disease, demands tailored therapeutic approaches due to its diverse subtypes and stages. This comprehensive review explores the intricate landscape of lung cancer research, delving into recent breakthroughs and their implications for diagnosis, therapy, and prevention. Genomic pr...
Several other aquaporins are overexpressed in a variety of cancer types (Table 1). Given the crucial role of water transport in the migration of tumor cells and of angiogenic endothelial cells, aquaporin inhibition has been suggested as a novel anticancer strategy [6]. Notably, no pharmacological...
Triple-negative breast cancer (TNBC), a highly aggressive subtype of breast cancer, negatively expresses estrogen receptor, progesterone receptor, and the human epidermal growth factor receptor 2 (HER2). Although chemotherapy is the main form of treatmen
practitioners, and scholars within the fields of Nanomedicine and Nanotechnology. Its commitment to open access and rigorous peer review ensures that the latest breakthroughs and discoveries are made accessible to a global audience, catalyzing progress and innovation within this dynamic and rapidly evolving...
1999). Although some breakthroughs have been made, there are still some unavoidable challenges in applying DNAzyme in cancer treatment. The first key issue is how to efficiently deliver DNAzymes to cancer cells. DNAzymes have to overcome multiple physiological barriers during transportation from the ...
Lung cancer continues to be the leading cause of cancer-related death worldwide. In the last decade, significant advancements in the diagnosis and treatment of lung cancer, particularly NSCLC, have been achieved with the help of molecular translational research. Among the hopeful breakthroughs in the...
This article critically evaluates recent breakthroughs, addresses the current challenges faced by researchers, and explores the future directions of topical and transdermal approaches in melanoma management. By presenting a summary of the latest research and predicting future trends, this review aims to ...
Glutamine emerges as a rising star in the field of cancer immunotherapy.AThe timeline of major breakthroughs in glutamine metabolism.BThe dynamic interplay between cancer cells and immune cells in their competition for the limited pool of available glutamine. GLS, glutaminase ...